Research Article
A Novel High-Content Screening-Based Method for Anti-Trypanosoma cruzi Drug Discovery Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Table 1
Cytotoxicity against hiPSC-CMs and anti-T. cruzi activity against intracellular amastigotes.
| ||||||||||||||||||||||||||||||||
CC50: cytotoxicity concentration 50%; EC50: effective concentration at 50% inhibitory concentration for inhibition of T. cruzi amastigotes. Values are of three independent experiments. |